Stay updated with breaking news from Nasdaq Vray. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
ViewRay (NASDAQ:VRAY – Get Rating) was downgraded by analysts at Stifel Nicolaus from a “buy” rating to a “hold” rating in a research note issued to investors on Friday, The Fly reports. They currently have a $1.75 target price on the stock, down from their previous target price of $7.00. Stifel Nicolaus’ target price would […]
Shares of ViewRay, Inc. (NASDAQ:VRAY – Get Rating) hit a new 52-week low during trading on Thursday . The company traded as low as $1.71 and last traded at $1.83, with a volume of 26276504 shares trading hands. The stock had previously closed at $3.01. Analysts Set New Price Targets A number of analysts have […]
ViewRay (NASDAQ:VRAY – Get Rating) had its price target cut by Morgan Stanley from $5.50 to $2.00 in a research report issued to clients and investors on Friday, The Fly reports. Morgan Stanley’s price target suggests a potential upside of 23.46% from the company’s current price. Several other equities research analysts have also recently weighed […]
ViewRay, Inc. (NASDAQ:VRAY – Get Rating) saw unusually large options trading activity on Thursday. Stock traders acquired 9,537 put options on the company. This is an increase of approximately 42% compared to the typical daily volume of 6,699 put options. Insiders Place Their Bets In related news, insider James F. Dempsey sold 42,000 shares of […]
ViewRay (NASDAQ:VRAY – Get Rating) and Movano (NASDAQ:MOVE – Get Rating) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, valuation, analyst recommendations, dividends, institutional ownership, risk and earnings. Insider and Institutional Ownership 84.4% of ViewRay shares are held by […]